Is CPRX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 17th of October 2014, Catalyst Pharmaceuticals had a stock price of $2.48. If you invested back then, your return now would be a profit of $19.18 per share or 773.39%
Yes, the average daily trading liquidity for Catalyst Pharmaceuticals is $18.56 million. You should therefore be able to get in and out of your positions relatively fast.
Catalyst Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 58.30, the company's ability to pay off the debt is good. Catalyst Pharmaceuticals has a good net profit margin of 15.69% and should have high tolerances against inflation.
We have calculated the inflation risk for Catalyst Pharmaceuticals to be low [0.1 out of 1]